Handbook of Tuberculosis: Clinics, Diagnostics, Therapy, and Epidemiology

Tuberculosis (TB), a deadly airborne disease caused by the bacterium Mycobacterium tuberculosis, takes the lives of almost 2 million people each year and is considered to be the most common infectious disease in the world. However, thanks to the efforts of researchers such as the volumes’ lead editor, Dr. Stefan H. E. Kaufmann, there have been several recent advances in fighting the disease.
Dr. Stefan Kaufmann, the Founding Director of the Max Planck Institute for Infection Biology in Berlin and Professor of Microbiology and Immunology at the Charité at the Humboldt University, Berlin, has published more than 600 scientific articles and currently serves as President of the European Federation of Immunological Societies and Chair of the Immunology Division of the American Society of Microbiology. Dr. Kaufmann is considered the world′s leading expert in the field of tuberculosis.
The Handbook of Tuberculosis, which explores the causes and available treatments of the widespread infection as well as current research into vaccination, is divided into three separate volumes covering different areas of study. Each volume provides an essential resource to molecular and cell biologists, bacteriologists, immunologists, pathologists and pathophysiologists, clinicians and those working in the pharmaceutical industry and interested in world health.
Volume 1: Molecular Biology and Biochemistry highlights the molecular mechanisms of tuberculosis.
Volume 2: Immunology and Cell Biology presents the pre–eminent resource for all aspects of cell biology and immunology of tuberculosis, including vaccine development.
Volume 3: Clinics, Diagnostics, Therapy and Epidemiology introduces a comprehensive overview of clinical aspects of tuberculosis, including drug resistance, epidemiological aspects and clinical trials. It is co–edited by Dr. Paul van Helden, Professor of Medical Biochemistry at Stellenbosch U niversity, South Africa, Director of Laboratory Research for the Desmond Tutu Tuberculosis Centre and former President of the South African Society of Biochemistry and Molecular Biology.

Spis treści:
Clinics Diagnostics Therapy Epidemiology: Introduction
Global Epidemiology of Tuberculosis
Surveillance Studies and Interpretation
Molecular Epidemiology of M. tuberculosis
Diagnosis of M. tuberculosis: Clinical
Clinical Disease (with and without HIV)
Management of Tuberculosis Patients
Chemotherapy
New Drugs and Clinical Drug Trials
Latency
Drug Resistance in Clinical Context
Novel Drug Treatment Strategies –
Co–infections
Modeling
BCG Vaccination

Nota biograficzna:
Prof. Dr. Stefan H.E. Kaufmann is Founding Director of the Max Planck Institute for Infection Biology, Berlin. He has published more than 600 scientific articles and is member of numerous scientific societies and committees e.g. current President of the European Federation of Immunological Societies, and Chair of the Immunology division of the American Society of Microbiology. He has won numerous prestigious awards including the Scientific Prize of Smith Kline Beecham and the Pettenkofer Prize.
Paul van Helden is Professor of Medical Biochemistry at Stellenbosch University, South Africa. He is Director of Laboratory Research for the Desmond Tutu TB Centre. He is a past president of the SA Society of Biochemistry and Molecular Biology, and has received the Gold medal of this society.